{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:51:15Z","timestamp":1791903075785,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1053\/berh.2001.0224","type":"journal-article","created":{"date-parts":[[2002,10,28]],"date-time":"2002-10-28T17:40:27Z","timestamp":1035826827000},"page":"245-264","source":"Crossref","is-referenced-by-count":35,"title":["Management of skin disease in patients with lupus erythematosus"],"prefix":"10.1053","volume":"16","author":[{"given":"Jeffrey P.","family":"Callen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/berh.2001.0224_RF1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0889-857X(21)00948-0","article-title":"Mucocutaneous changes in patients with lupus erythematosus: the relationship of these lesions to systemic disease","volume":"14","author":"Callen","year":"1988","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1053\/berh.2001.0224_RF2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","article-title":"Distinctive cutaneous subsets in the spectrum of lupus erythematosus","volume":"4","author":"Gilliam","year":"1981","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF3","series-title":"Cutaneous Medicine","article-title":"Lupus erythematosus","author":"Provost","year":"2001"},{"key":"10.1053\/berh.2001.0224_RF4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archderm.1982.01650180046015","article-title":"Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients","volume":"118","author":"Callen","year":"1982","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF5","first-page":"256","article-title":"Clinical, serologic and immunogenetic studies in patients with chronic cutaneous (discoid) lupus erythematosus who have verrucous and\/or hypertrophic skin lesions","volume":"15","author":"Spann","year":"1988","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0224_RF6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.136.8.1033","article-title":"Lupus erythematosus tumidus \u2013 a neglected subset of cutaneous lupus erythematosus: report of 40 cases","volume":"136","author":"Kuhn","year":"2000","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1562\/0031-8655(2001)073<0532:PILETR>2.0.CO;2","article-title":"Phototesting in lupus erythematosus tumidus \u2013 review of 60 patients","volume":"73","author":"Kuhn","year":"2001","journal-title":"Photochemistry and Photobiology"},{"key":"10.1053\/berh.2001.0224_RF8","first-page":"68","article-title":"Lupus panniculitis: clinical perspective from a case series","volume":"26","author":"Martens","year":"1999","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0224_RF9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.1979.04010120007006","article-title":"Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset","volume":"115","author":"Sontheimer","year":"1979","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780310811","article-title":"Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients","volume":"31","author":"Callen","year":"1988","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0224_RF11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0190-9622(89)70070-0","article-title":"Annular erythema: a possible association with primary Sjogren's syndrome","volume":"20","author":"Teramoto","year":"1989","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.2001.0224_RF13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0046-8177(97)90281-1","article-title":"Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy","volume":"28","author":"Crowson","year":"1997","journal-title":"Human Pathology"},{"key":"10.1053\/berh.2001.0224_RF14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1067\/mjd.2001.114565","article-title":"Terbinafine-induced subacute cutaneous lupus erythematosus","volume":"44","author":"Bonsmann","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF15","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.137.9.1196","article-title":"Subacute cutaneous lupus erythematosus associated with terbinafine therapy","author":"Callen","year":"2001","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1067\/mjd.2001.116583","article-title":"Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized","volume":"45","author":"Callen","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/096120339700600208","article-title":"Cutaneous lupus erythematosus during the neonatal and childhood periods","volume":"6","author":"Lee","year":"1997","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0224_RF18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1067\/mpd.2000.109108","article-title":"Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry","volume":"137","author":"Neiman","year":"2000","journal-title":"Journal of Pediatrics"},{"key":"10.1053\/berh.2001.0224_RF19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0190-9622(90)70020-I","article-title":"Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation","volume":"22","author":"Lehmann","year":"1990","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-97-2-165","article-title":"Bullous eruption of systemic lupus erythematosus: dramatic response to dapsone therapy","volume":"97","author":"Hall","year":"1982","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.2001.0224_RF21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/berh.1999.0082","article-title":"The anti-phospholipid antibody syndrome: clinical and serological aspects","volume":"14","author":"Alarcon-Segovia","year":"2000","journal-title":"Bailli\u00e8res Clinical Rheumatology"},{"key":"10.1053\/berh.2001.0224_RF22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archderm.1991.01680060080008","article-title":"Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence","volume":"127","author":"Fabre","year":"1991","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1529-8019.2001.014002061.x","article-title":"Therapy of cutaneous lupus erythematosus","volume":"14","author":"Callen","year":"2001","journal-title":"Dermatologic Therapy"},{"key":"10.1053\/berh.2001.0224_RF24","first-page":"231","article-title":"Report of an association between discoid lupus erythematosus and smoking","volume":"63","author":"Gallego","year":"1999","journal-title":"Cutis"},{"key":"10.1053\/berh.2001.0224_RF25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.1997.tb14899.x","article-title":"Occurrence of polymorphous light eruption in lupus erythematosus","volume":"136","author":"Nyberg","year":"1997","journal-title":"British Journal of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096120330000900103","article-title":"Photosensitivity in lupus","volume":"9","author":"Millard","year":"2000","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0224_RF27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1600-0781.2000.160604.x","article-title":"Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test","volume":"16","author":"Stege","year":"2000","journal-title":"Photodermatology, Photoimmunology and Photomedicine"},{"key":"10.1053\/berh.2001.0224_RF28","first-page":"1716","article-title":"Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus","volume":"25","author":"Rahman","year":"1998","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0224_RF29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1067\/mjd.2000.103635","article-title":"Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment","volume":"42","author":"Jewell","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000246899","article-title":"The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus","volume":"189","author":"Feldmann","year":"1994","journal-title":"Dermatology"},{"key":"10.1053\/berh.2001.0224_RF31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000246710","article-title":"Chloroquine-quinacrine association in resistant cutaneous lupus","volume":"190","author":"Lipsker","year":"1995","journal-title":"Dermatology"},{"key":"10.1053\/berh.2001.0224_RF32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1191\/096120300678828082","article-title":"The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients","volume":"9","author":"Toubi","year":"2000","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0224_RF33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1191\/096120399678847713","article-title":"A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with dapsone","volume":"8","author":"Neri","year":"1999","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0224_RF34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1440-0960.1980.tb00162.x","article-title":"Further study of the use of clofazimine in discoid lupus erythematosus","volume":"21","author":"Krivanek","year":"1980","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000018345","article-title":"Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases","volume":"200","author":"Rudnicka","year":"2000","journal-title":"Dermatology"},{"key":"10.1053\/berh.2001.0224_RF36","first-page":"151","article-title":"Traitment du lupus erythemateux chronique par la sulfasalazine: 11 observations","volume":"124","author":"Delaporte","year":"1997","journal-title":"Annals of Dermatology and Venereology"},{"key":"10.1053\/berh.2001.0224_RF37","first-page":"21","article-title":"Sulfasalazine in the treatment of cutaneous lupus erythematosus: open trial in six cases","volume":"7","author":"Lagrange","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0224_RF38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.1986.tb05720.x","article-title":"Treatment of chronic discoid lupus erythematosus with an oral gold compound (Auranofin)","volume":"115","author":"Dalziel","year":"1986","journal-title":"British Journal of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF39","first-page":"487","article-title":"Treatment of cutaneous lesions of systemic lupus erythematosus with thalidomide","volume":"11","author":"Atra","year":"1993","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1053\/berh.2001.0224_RF40","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archderm.135.9.1079","article-title":"American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus","volume":"135","author":"Duong","year":"1999","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF41","first-page":"1429","article-title":"Thalidomide in the treatment of cutaneous lupus erythematosus refractory to conventional therapy","volume":"27","author":"Ordi-Ros","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0224_RF42","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archderm.131.5.620b","article-title":"Phenytoin in the treatment of discoid lupus erythematosus","volume":"131","author":"Rodriquez-Castellanos","year":"1995","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archderm.1986.01660140060018","article-title":"Mechanism-oriented assessment of isotretinoin in chronic of subacute cutaneous lupus erythematosus","volume":"122","author":"Newton","year":"1986","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2340\/0001555565324329","article-title":"Treatment of cutaneous lupus erythematosus with etretinate","volume":"65","author":"Ruzicka","year":"1985","journal-title":"Acta Dermatologica Venereologica"},{"key":"10.1053\/berh.2001.0224_RF45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archderm.1991.04510010083008","article-title":"Azathioprine: an effective, corticosteroids-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis","volume":"127","author":"Callen","year":"1991","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s002960050058","article-title":"Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms","volume":"18","author":"Boehm","year":"1998","journal-title":"Rheumatology International"},{"key":"10.1053\/berh.2001.0224_RF47","first-page":"S110","article-title":"Mycophenolate mofetil for systemic lupus erythematosus","volume":"41","author":"Pashinian","year":"1998","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0224_RF48","article-title":"High dose intravenous immune globulin in the treatment of refractory severe discoid lupus erythematosus","author":"Lagrange","year":"2002","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF49","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archderm.135.9.1124","article-title":"High-dose intravenous immunoglobulin in cutaneous lupus erythematosus","volume":"135","author":"Genereau","year":"1999","journal-title":"Archives of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF50","doi-asserted-by":"crossref","first-page":"142S","DOI":"10.1111\/1523-1747.ep12875049","article-title":"Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a","volume":"95","author":"Nicolas","year":"1990","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1053\/berh.2001.0224_RF51","first-page":"253","article-title":"Therapy of cutaneous lupus erythematosus with recombinant interferon alpha-2a","volume":"2","author":"Tebbe","year":"1992","journal-title":"European Journal of Dermatology"},{"key":"10.1053\/berh.2001.0224_RF52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0190-9622(96)80119-8","article-title":"Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412","volume":"34","author":"Prinz","year":"1996","journal-title":"Journal of the American Academy of Dermatology"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694201902244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694201902244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T22:16:50Z","timestamp":1704320210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694201902244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S1521694201902244"],"URL":"https:\/\/doi.org\/10.1053\/berh.2001.0224","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}